Ceftaroline fosamil
- Generic Name
- Ceftaroline fosamil
- Brand Names
- Teflaro, Zinforo
- Drug Type
- Small Molecule
- Chemical Formula
- C22H21N8O8PS4
- CAS Number
- 229016-73-3
- Unique Ingredient Identifier
- 7P6FQA5D21
Overview
Ceftaroline fosamil is a cephalosporin antibacterial indicated for the treatment of the following infections caused by designated susceptible bacteria: Acute bacterial skin and skin structure infections. Community-acquired bacterial pneumonia.
Background
Ceftaroline fosamil is a cephalosporin antibacterial indicated for the treatment of the following infections caused by designated susceptible bacteria: Acute bacterial skin and skin structure infections. Community-acquired bacterial pneumonia.
Indication
Ceftaroline fosamil is indicated for the treatment of patients with the following infections caused by susceptible isolates of the designated microorganisms.
Associated Conditions
- Acute Bacterial Skin and Skin Structure Infection (ABSSSI)
- Community-Acquired Bacterial Pneumonia (CABP)
Clinical Trials
FDA Approved Products
Teflaro
Manufacturer:Allergan, Inc.
Route:INTRAVENOUS
Strength:600 mg in 20 mL
Approved: 2022/11/17
NDC:0456-0600
Teflaro
Manufacturer:Allergan, Inc.
Route:INTRAVENOUS
Strength:400 mg in 20 mL
Approved: 2022/11/17
NDC:0456-0400
Singapore Approved Products
Zinforo Powder for Concentrate for Solution for Infusion 600mg/vial
Manufacturer:ACS Dobfar S.p.A., ACS Dobfar S.p.A. (intermediate – sterile bulk drug product blend)
Form:INJECTION, POWDER, FOR SOLUTION
Strength:530 mg/vial
Online:Yes
Approved: 2012/11/15
Approval:SIN14268P
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath